Jarushka Naidoo: Join the ESMO Immuno24 next week in Geneva
Jarushka Naidoo shared a post by ESMO on X:
“Join us for ESMO Immuno24 next week in Geneva!
Some great sessions:
- Joint ESMO-SITC Primer: core concepts in immunology
- Keynote speaker Ton Schumacher, The Netherlands Cancer Institute
- Proffered papers CM73L, Solange Peters
- Immune Tox session, Jarushka Naidoo, Christina Ruhlmann “
Quoting ESMO’s post:
“Last Chance to Save on Registration
Exciting times ahead! Late-breaking abstract authors-titles are now online!
Head to the programme to see the science you can look forward to and register today!
For registration click here.”
Dr. Jarushka Naidoo is a thoracic oncologist at the Beaumont Hospital Dublin (Ireland), Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University. She currently serves as national lung cancer lead for Cancer Trials Ireland. She serves on several international guideline panels including ASCO and SITC (Society of Immunotherapy for Cancer), and is an experienced clinical trialist- having developed and completed several investigator-initiated, industry-funded and cooperative group clinical trials.
She has received a number of grants including a young investigator award from the International Association for the Study of Lung Cancer (IASLC), Lung Cancer Foundation of America (LCFA), and a career development award from the National Institutes of Health (NIH) KL2-program. She is the IASLC Communications Committee Chair.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023